The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the world’s largest funder of biomedical research. Its mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability. Composed of 27 Institutes and Centers, NIH funds research grants in all fifty states and around the world in order to find medical discoveries that improve people’s health, understand disease, and save lives. Learn more about the positive impact NIH funding has on health, communities, and the economy.
The Parkinson’s Action Network (PAN) actively pursues increased funding for NIH in order to find better treatments and a cure for Parkinson’s disease.
On April 2, 2013, President Obama announced a new research initiative, the Brain Research through Advancing Neurotechnologies (BRAIN) Initiative. The Initiative aims to revolutionize our understanding of the human brain by bringing together the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA), and the National Science Foundation (NSF) as well as key private sector partners, like the Allen Institute for Brain Research.
The NIH is the largest single funder of Parkinson’s disease research in the world. The National Institute of Neurological Disorders and Stroke (NINDS) supports a broad spectrum of basic, translational, and clinical research on Parkinson’s disease.
Morris K. Udall Parkinson’s Disease Research Centers of Excellence fund Parkinson’s research at 10 centers across the country. These centers utilize a multidisciplinary research approach to learn about the fundamental causes of Parkinson’s disease as well as to improve the diagnosis and treatment of Parkinson’s and related neurodegenerative disorders.
PAN works to ensure the promising field of stem cell research is adequately supported by the federal government.